405 related articles for article (PubMed ID: 22925832)
1. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
[TBL] [Abstract][Full Text] [Related]
2. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
4. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
Rethorst CD; Greer TL; Toups MS; Bernstein I; Carmody TJ; Trivedi MH
Transl Psychiatry; 2015 Aug; 5(8):e611. PubMed ID: 26241349
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.
Song C; Halbreich U; Han C; Leonard BE; Luo H
Pharmacopsychiatry; 2009 Sep; 42(5):182-8. PubMed ID: 19724980
[TBL] [Abstract][Full Text] [Related]
6. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
[TBL] [Abstract][Full Text] [Related]
7. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.
Hernández ME; Mendieta D; Martínez-Fong D; Loría F; Moreno J; Estrada I; Bojalil R; Pavón L
Eur Neuropsychopharmacol; 2008 Dec; 18(12):917-24. PubMed ID: 18805677
[TBL] [Abstract][Full Text] [Related]
8. Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
Rethorst CD; Sunderajan P; Greer TL; Grannemann BD; Nakonezny PA; Carmody TJ; Trivedi MH
Psychol Med; 2013 Apr; 43(4):699-709. PubMed ID: 23171815
[TBL] [Abstract][Full Text] [Related]
9. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Hannestad J; DellaGioia N; Bloch M
Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103
[TBL] [Abstract][Full Text] [Related]
10. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression.
Ranjbar E; Shams J; Sabetkasaei M; M-Shirazi M; Rashidkhani B; Mostafavi A; Bornak E; Nasrollahzadeh J
Nutr Neurosci; 2014 Feb; 17(2):65-71. PubMed ID: 23602205
[TBL] [Abstract][Full Text] [Related]
11. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
12. Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
Shelton RC; Pencina MJ; Barrentine LW; Ruiz JA; Fava M; Zajecka JM; Papakostas GI
J Clin Psychiatry; 2015 Dec; 76(12):1635-41. PubMed ID: 26613389
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
Eller T; Vasar V; Shlik J; Maron E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):445-50. PubMed ID: 17976882
[TBL] [Abstract][Full Text] [Related]
14. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison.
Trivedi MH; Greer TL; Church TS; Carmody TJ; Grannemann BD; Galper DI; Dunn AL; Earnest CP; Sunderajan P; Henley SS; Blair SN
J Clin Psychiatry; 2011 May; 72(5):677-84. PubMed ID: 21658349
[TBL] [Abstract][Full Text] [Related]
15. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.
Mao R; Zhang C; Chen J; Zhao G; Zhou R; Wang F; Xu J; Yang T; Su Y; Huang J; Wu Z; Cao L; Wang Y; Hu Y; Yuan C; Yi Z; Hong W; Wang Z; Peng D; Fang Y
J Affect Disord; 2018 Sep; 237():65-72. PubMed ID: 29778935
[TBL] [Abstract][Full Text] [Related]
16. Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients.
Rizavi HS; Ren X; Zhang H; Bhaumik R; Pandey GN
Psychiatry Res; 2016 Jun; 240():314-320. PubMed ID: 27138824
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, inflammation and treatment response in major depression.
Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
[TBL] [Abstract][Full Text] [Related]
18. Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression.
Schmidt FM; Schröder T; Kirkby KC; Sander C; Suslow T; Holdt LM; Teupser D; Hegerl U; Himmerich H
Psychiatry Res; 2016 May; 239():85-91. PubMed ID: 27137966
[TBL] [Abstract][Full Text] [Related]
19. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
Fourrier C; Sampson E; Mills NT; Baune BT
Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
